Domain Therapeutics

is a France-based biopharmaceutical company that researches and develops GPCR-mediated immunotherapies for the treatment of cancer...
Read more
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$52.8M
Acquisitions
2
Investments
1

News

Apr 01, 2025
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics to Present Data on its GPCR Lead Programs at AACR Annual Meeting 2025
Mar 20, 2025
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics Discloses DT-9046 as a Groundbreaking Oral Drug Candidate for Inflammatory Diseases
Jun 06, 2024
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics Strengthens Its Intellectual Property for Its Series of Treg Depleting anti-CCR8 Antibodies, Including Best-in-class Candidate DT-7012
Apr 08, 2024
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics to Participate at Premier Investor and Healthcare Conferences
Mar 26, 2024
Business Wire
Domain Therapeutics: Domain Therapeutics to Present Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology, at AACR 2024 Annual Meeting, Highlighting Clear Competitive Advantages of This Candidate
Mar 12, 2024
Contract Pharma
Domain Therapeutics: Domain Therapeutics & Chime Biologics Sign Manufacturing Service Agreement
Feb 23, 2024
Domain Therapeutics Youtube Channel
Domain Therapeutics posted a video "Domain Therapeutics - Discover more than you think" on YOUTUBE
Jan 25, 2024
BioSpace
Domain Therapeutics: Domain Therapeutics Awarded Hospital-University Research in Health (RHU) SPRINT Consortium Grant to Progress Its Proprietary CCR8 Antibody Candidate to the Clinic
Jan 08, 2024
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics Strengthens Leadership Team to Spearhead Global Development and North American Expansion as the Leading GPCR Immuno-Oncology Company
Jan 08, 2024
Domain Therapeutics Vimeo Channel
Domain Therapeutics posted a video "Domain_-_animation_site_web_1982x971-BGblanc" on VIMEO

Domain Therapeutics Competitors

1OSE Immunotherapeutics
2Innate Pharma
3Cellectis
4Verastem Oncology
5Pharmacyclics
6TG Therapeutics
7Arena

Trending Companies